Literature DB >> 30663874

Photothermal-Controlled Generation of Alkyl Radical from Organic Nanoparticles for Tumor Treatment.

Rui Xia1,2, Xiaohua Zheng1,2, Xiuli Hu1, Shi Liu1, Zhigang Xie1,2.   

Abstract

The therapeutic properties of light are well known for photodynamic or photothermal therapy, which could cause irreversible photodamage to tumor tissues. Although photodynamic therapy (PDT) has been proved in the clinic, the efficacy is not satisfactory because of complicated tumor microenvironments. For example, the hypoxia in solid tumor has a negative effect on the generation of singlet oxygen. To address the hypoxia issues in PDT, leveraging alkyl radical is an available option due to the oxygen-independent feature. In this work, a new kind of organic nanoparticles (tripolyphosphate (TPP)-NN NPs) from porphyrin and radical initiator is developed. Under near-infrared light irradiation, TPP-NN NPs will split and release alkyl radical, which could induce obvious cytotoxicity both in normal and hypoxia environment. The photothermal-controlled generation of alkyl radical could significantly inhibit the growth of cervical cancer and show ignorable systemic toxicity. This activatable radical therapy opens up new possibilities for the application of PDT in hypoxia condition.

Entities:  

Keywords:  alkyl radical; photodynamic therapy; porphyrin; supramolecular nanoparticles

Mesh:

Substances:

Year:  2019        PMID: 30663874     DOI: 10.1021/acsami.8b18953

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  5 in total

1.  Cascade Drug-Release Strategy for Enhanced Anticancer Therapy.

Authors:  Xu Zhang; Sheng Wang; Guohui Cheng; Peng Yu; Jin Chang; Xiaoyuan Chen
Journal:  Matter       Date:  2021-01-06

2.  Biological Evaluation of Naproxen-Dehydrodipeptide Conjugates with Self-Hydrogelation Capacity as Dual LOX/COX Inhibitors.

Authors:  Rute Moreira; Peter J Jervis; André Carvalho; Paula M T Ferreira; José A Martins; Patrícia Valentão; Paula B Andrade; David M Perreira
Journal:  Pharmaceutics       Date:  2020-02-03       Impact factor: 6.321

Review 3.  Research Progress of Conjugated Nanomedicine for Cancer Treatment.

Authors:  Bin Zhao; Sa Chen; Ye Hong; Liangliang Jia; Ying Zhou; Xinyu He; Ying Wang; Zhongmin Tian; Zhe Yang; Di Gao
Journal:  Pharmaceutics       Date:  2022-07-21       Impact factor: 6.525

4.  Nanozyme hydrogel for enhanced alkyl radical generation and potent antitumor therapy.

Authors:  Shipeng Ning; Zeming Liu; Mingzhu Chen; Daoming Zhu; Qinqin Huang
Journal:  Nanoscale Adv       Date:  2022-08-16

Review 5.  Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy.

Authors:  Liang Hong; Jiangmin Li; Yali Luo; Tao Guo; Chenshuang Zhang; Sha Ou; Yaohang Long; Zuquan Hu
Journal:  Biomolecules       Date:  2022-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.